Roles and Mechanisms of Hawthorn and Its Extracts on Atherosclerosis: A Review

Min Wu1, Longtao Liu2, Yanwei Xing1

  • 1Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Insights

Hawthorn extracts show promise in treating cardiovascular disease (CVD) by lowering blood lipids and protecting blood vessels. This traditional remedy offers a natural approach to managing atherosclerosis and improving heart health.

Area of Science:

  • Integrative medicine and cardiovascular pharmacology.
  • Traditional Chinese Medicine (TCM) and its application in modern therapeutics.

Background:

  • Cardiovascular disease (CVD), particularly atherosclerosis, represents a significant global health burden, leading to high morbidity and mortality.
  • Hawthorn has a long history of medicinal use, with documented applications for cardiovascular conditions dating back centuries in China.
  • TCM theory suggests hawthorn aids digestion and improves circulation by reducing blood stasis, providing a traditional basis for its use.

Purpose of the Study:

  • To review the scientific evidence supporting the use of hawthorn extracts for cardiovascular health.
  • To elucidate the principal mechanisms by which hawthorn exerts its cardioprotective effects, focusing on atherosclerosis.
  • To provide a theoretical foundation for the expanded clinical application of hawthorn in managing CVD.

Main Methods:

  • Systematic review of existing literature on hawthorn's effects on cardiovascular health.
  • Analysis of studies investigating hawthorn extracts' impact on serum lipids, oxidative stress, inflammation, and vascular function.
  • Synthesis of findings to identify key pharmacological mechanisms.

Main Results:

  • Hawthorn extracts demonstrate significant serum lipid-lowering properties.
  • Extracts exhibit potent anti-oxidative and anti-inflammatory activities.
  • Evidence supports hawthorn's role in protecting vascular endothelium and mitigating atherosclerotic processes.

Conclusions:

  • Hawthorn extracts possess scientifically validated lipid-lowering, anti-oxidative, and cardiovascular protective effects.
  • The primary mechanisms include modulating blood lipids, combating oxidative stress, reducing inflammation, and preserving endothelial function.
  • These findings establish a strong theoretical basis for utilizing hawthorn as a therapeutic agent against atherosclerosis and other CVDs.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
272
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
684
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.2K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
300
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
823